Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 66

Sort by

Sort Order Select

Journal Articles

Phase 2 Multicenter Study of Tazemetostat, an EZH2 Inhibitor, in Patients with Relapsed or Refractory Follicular Lymphoma

Franck Morschhauser, MD PhD, Herve Tilly, MD PhD, Aristeidis Chaidos, Tycel J. Phillips, MD, Vincent Ribrag, MD, Philip Campbell, MBBS, FRACP, FRCPA, Damaj Gandhi Laurent, MD PhD, Wojciech Jurczak, MD PhD, Pamela McKay, MD, Stephen Opat, John Radford, Jennifer Whalen, Anand Rajarethinam, Susan Benedict Navia, Deyaa Adib, Gilles Salles, MD PhD

Blood (2019) 134 (Supplement_1): 123.

https://doi.org/10.1182/blood-2019-128096

Published: 2019

Journal Articles

Potential Genetic and Immunologic Mechanisms of Therapeutic Resistance and Disease Progression in CNS Lymphoma Elucidated Via Whole Brain Autopsy Studies

David A. Solomon, MD, PhD, Huimin Geng, PhD, Raymond A. Sobel, MD, Lakshmi Subbaraj, B.S., Mazie Tsang, MD, James L. Rubenstein, MD PhD

Blood (2019) 134 (Supplement_1): 1494.

https://doi.org/10.1182/blood-2019-131302

Published: 2019

Journal Articles

Computational Systems Biology Models for the Identification of Metabolic Vulnerabilities in Multiple Myeloma

Luis Vitores V. Valcárcel, MSc, Raquel Ordoñez, PhD, Iñigo Apaolaza, MSc, Ana Valcárcel, Leire Garate, Cem Meydan, PhD, Bruno Paiva, PhD, Ari M Melnick, MD, Jesús San-Miguel, Francisco J. Planes, Xabier Agirre, PhD, Felipe Prosper, MD PhD

Blood (2019) 134 (Supplement_1): 3084.

https://doi.org/10.1182/blood-2019-123970

Published: 2019

Journal Articles

Characterization of Complete Lncrnas Transcriptome Reveals Expression of Lncrnas As a Prognostic Factor and Linc-Smilo As a Potential Therapeutic Target in Multiple Myeloma

Blood (2019) 134 (Supplement_1): 4323.

https://doi.org/10.1182/blood-2019-123008

Published: 2019

Journal Articles

Lncrnas As New Partners of Novel Chimeric Transcripts in Multiple Myeloma

Ane Amundarain, Luis Vitores Valcárcel, MSc, Raquel Ordoñez, PhD, Leire Garate, Estíbaliz Miranda, Xabier Cendoya, Maria Jose Calasanz, PhD BSc, Bruno Paiva, PhD, Jesús San-Miguel, Francisco J Planes, Felipe Prósper, MD PhD, Xabier Agirre, PhD

Blood (2019) 134 (Supplement_1): 4356.

https://doi.org/10.1182/blood-2019-122568

Published: 2019

Journal Articles

Prognostic Biomarkers Converge on a Germinal Centre Dark Zone Phenotype As a Determinant of Adverse Outcome in Follicular Lymphoma Patients Treated with Rituximab and Chemotherapy

Anjali Silva, PhD MSc, BSc, Clementine Sarkozy, MD, Tracy Lackraj, PhD BSc, Anja Mottok, Vindi Jurinovic, MSc, Laurie H Sehn, MD MPH, Oliver Weigert, MD, Christian Steidl, MD, Robert Kridel, PhD MD

Blood (2018) 132 (Supplement 1): 4095.

https://doi.org/10.1182/blood-2018-99-112689

Published: 2018

Journal Articles

Follicular Lymphoma Grade 3A Exhibits Pathological and Cytogenetic Diversity, but Similar Prognosis Compared to FL Grade 1-2: Pooled Analysis of 1757 Follicular Lymphomas from the PRIMA and Relevance Trials

Camille Laurent, MD PhD, Danielle Canioni, MD, Bettina Fabiani, MD, Véronique Meignin, Catherine Chassagne-Clément, MD, Peggy Dartigues-Cuillères, MD, Christiane Copie, MDPhD, Guillaume Cartron, Franck Morschhauser, MD, Gilles Salles, MD PhD, Luc Xerri, MD PhD

Blood (2018) 132 (Supplement 1): 778.

https://doi.org/10.1182/blood-2018-99-115831

Published: 2018

Journal Articles

Pan-HDAC Inhibitors May Restore PRDM1 Expression in Follicular Lymphoma

Thierry Fest, Fabienne Desmots-Loyer, Mikael Roussel, MD PhD, Celine Pangault, PhD, Cedric Pastoret, MD, Francisco Llamas-Gutierrez, Eric Guiheneuf, Valérie Camara-clayette, Thierry Lamy, Pr, MD PhD, Karin Tarte, PhD, Vincent Ribrag, MD

Blood (2018) 132 (Supplement 1): 2848.

https://doi.org/10.1182/blood-2018-99-113269

Published: 2018

Journal Articles

Effect of Histologic Grade on Clinical Outcomes of Follicular Lymphoma: Prolonged Progression Free Survival of Grade 3 Follicular Lymphoma in the Rituximab Era

Suchitra Sundaram, MBBS, Erika Moore, MD, Sabarish Ayyappan, MBBS, Fahrettin Covut, MD, Benjamin Tomlinson, MD, Richard Creger, PhD, Ehsan Malek, MD, Leland Metheny, MD, Brenda W. Cooper, MD, Hillard M Lazarus, MD, Marcos de Lima, MD, Paolo Caimi, MD

Blood (2017) 130 (Supplement 1): 2775.

https://doi.org/10.1182/blood.V130.Suppl_1.2775.2775

Published: 2017

Journal Articles

Two Variants of Follicular Lymphoma Grade 3

Lyubov V. Plastinina, Alla M. Kovrigina, MD PhD, Sergey K. Kravchenko, MD PhD, Tatiana N. Obukhova, MD PhD, Ekaterina S. Nesterova, MD PhD, Aminat U. Magomedova, MD PhD, Yana K. Mangasarova, MD PhD, Anna E. Misyurina, PhD MD, Fatima Babayeva, Sergei M. Kulikov, PhD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 5161.

https://doi.org/10.1182/blood.V130.Suppl_1.5161.5161

Published: 2017

Journal Articles

Bone Marrow Involvement in Primary Mediastinal B-Cell Large-Cell Lymphoma

Ekaterina Alexsandrovna Fastova, Aminat U. Magomedova, MD PhD, Alla M. Kovrigina, MD PhD, Yana K. Mangasarova, MD PhD, Sergey K. Kravchenko, MD PhD, Valeriy G. Savchenko, Andrey I. Vorobiev

Blood (2017) 130 (Supplement 1): 5239.

https://doi.org/10.1182/blood.V130.Suppl_1.5239.5239

Published: 2017

Journal Articles

B-Cell Differentiation Dependent Classification of Diffuse Large B-Cell Lymphoma By the Nanostring Technology

Thomas Yssing Michaelsen, BS, Rasmus Froberg Brøndum, Senior Bioinformatician, Julia Richter, PhD, Wolfram Klapper, MD, Mads Albertsen, Associate Professor, Hans Erik Johnsen, MD Professor, Karen Dybkær, Professor, Tarec Christoffer El-Galaly, MD PhD, Martin Bøgsted, Professor

Blood (2017) 130 (Supplement 1): 3995.

https://doi.org/10.1182/blood.V130.Suppl_1.3995.3995

Published: 2017

Journal Articles

Molecular Features of Germinal Cell Derived B-Cell Lymphomas Using miRNA Signatures

Aisha Al-Khinji, MD, Ellen Leich, Tathiana Andrade, Alyssa Bouska, PhD, Waseem Lone, PhD, Stefan Constinean, MD, Kai Fu, MD PhD, Andreas Rosenwald, MD, Wing Chung Chan, MD, Javeed Iqbal, PhD

Blood (2016) 128 (22): 5288.

https://doi.org/10.1182/blood.V128.22.5288.5288

Published: 2016

Journal Articles

Clinical, Biological Characteristics and Outcome of Pediatric Follicular Lymphoma at Children's Cancer Hospital - Egypt: A Single Center Experience

Shaimaa Samir Eissa, MD PhD, Samah Fathy Semary, MD, Asmaa Salama, MD, Alaa M Elhaddad, MD PhD

Blood (2016) 128 (22): 5343.

https://doi.org/10.1182/blood.V128.22.5343.5343

Published: 2016

Journal Articles

MYC-ID3 Pathway in a Cohort of Diffuse Large B Cell Lymphomas: Immunoistochemical Analysis and Prognostic Implications

Elisa Doni, MD, Fabio Pagni, MD, Fausto Rossini, MD, Angelo Belotti, MD, Silvia Bolis, MD, Ivana Casaroli, MD, Giorgio Cattoretti, MD, Pietro Enrico Pioltelli, MD, Carlo Gambacorti-Passerini, MD

Blood (2016) 128 (22): 5310.

https://doi.org/10.1182/blood.V128.22.5310.5310

Published: 2016

Journal Articles

High Expression of CXCR4 Impairs Anti-CD20 Monoclonal Antibody (Rituximab)-Dependent Cytotoxicity in Diffuse Large B-Cell Lymphoma

Linn Rønlev Reinholdt, PhDStudent, Maria Bach Laursen, PhD, Steffen Falgreen, PhD, Alexander Schmitz, Dr. rer. nat., Julie Støve Bødker, PhD, Martin Boegsted, Professor MSO, Hans Erik Johnsen, Professor, MD, Karen Dybkaer, Professor MSO

Blood (2015) 126 (23): 1455.

https://doi.org/10.1182/blood.V126.23.1455.1455

Published: 2015

Journal Articles

Management of Grade 3B Follicular Lymphoma (FL) Outside Clinical Trials: A Multicentric Retrospective Analysis on Behalf of Fondazione Italiana Linfomi (FIL)

Barbara Botto, Federica Cavallo, Manuela Zanni, Antonella Anastasia, Chiara Rusconi, Annalisa Chiarenza, Angela Ferrari, Sara Rattotti, Alessandra Dondi, Marco Calabrese, Andrea Evangelista, Umberto Vitolo, Massimo Federico, Giuseppe Rossi, MD

Blood (2015) 126 (23): 2716.

https://doi.org/10.1182/blood.V126.23.2716.2716

Published: 2015

Journal Articles

Tumor Vs Normal Gene Expression Profiles Identify Deregulated Pathways in ETV6/RUNX1 Positive Acute Lymphoblastic Leukemia: A Microarray-Based Meta-Analysis

Thomas Heiden, PhD, Janette Nickel, Robert Preissner, PhD, Karl Seeger, Prof. PhD

Blood (2015) 126 (23): 4812.

https://doi.org/10.1182/blood.V126.23.4812.4812

Published: 2015

Journal Articles

A Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes with Prognosis

Blood (2014) 124 (21): 2973.

https://doi.org/10.1182/blood.V124.21.2973.2973

Published: 2014

Journal Articles

Mirna-181a expression Lead to Longer Animal Survival and Slower Tumor-Growth Rate in Diffuse Large B-Cell Lymphoma Xenograft Models

Goldi A Kozloski, PhD, Xiaoyu Jiang, PhD, Shruti Bhatt, PhD, Rita Shaknovich, MD PhD, Ari M Melnick, MD, Izidore S Lossos, MD

Blood (2014) 124 (21): 2963.

https://doi.org/10.1182/blood.V124.21.2963.2963

Published: 2014

NARROW

Phase 2 Multicenter Study of Tazemetostat, an EZH2 Inhibitor, in Patients with Relapsed or Refractory Follicular Lymphoma

Potential Genetic and Immunologic Mechanisms of Therapeutic Resistance and Disease Progression in CNS Lymphoma Elucidated Via Whole Brain Autopsy Studies

Computational Systems Biology Models for the Identification of Metabolic Vulnerabilities in Multiple Myeloma

Characterization of Complete Lncrnas Transcriptome Reveals Expression of Lncrnas As a Prognostic Factor and Linc-Smilo As a Potential Therapeutic Target in Multiple Myeloma

Lncrnas As New Partners of Novel Chimeric Transcripts in Multiple Myeloma

Prognostic Biomarkers Converge on a Germinal Centre Dark Zone Phenotype As a Determinant of Adverse Outcome in Follicular Lymphoma Patients Treated with Rituximab and Chemotherapy

Follicular Lymphoma Grade 3A Exhibits Pathological and Cytogenetic Diversity, but Similar Prognosis Compared to FL Grade 1-2: Pooled Analysis of 1757 Follicular Lymphomas from the PRIMA and Relevance Trials

Pan-HDAC Inhibitors May Restore PRDM1 Expression in Follicular Lymphoma

Effect of Histologic Grade on Clinical Outcomes of Follicular Lymphoma: Prolonged Progression Free Survival of Grade 3 Follicular Lymphoma in the Rituximab Era

Two Variants of Follicular Lymphoma Grade 3

Bone Marrow Involvement in Primary Mediastinal B-Cell Large-Cell Lymphoma

B-Cell Differentiation Dependent Classification of Diffuse Large B-Cell Lymphoma By the Nanostring Technology

Molecular Features of Germinal Cell Derived B-Cell Lymphomas Using miRNA Signatures

Clinical, Biological Characteristics and Outcome of Pediatric Follicular Lymphoma at Children's Cancer Hospital - Egypt: A Single Center Experience

MYC-ID3 Pathway in a Cohort of Diffuse Large B Cell Lymphomas: Immunoistochemical Analysis and Prognostic Implications

High Expression of CXCR4 Impairs Anti-CD20 Monoclonal Antibody (Rituximab)-Dependent Cytotoxicity in Diffuse Large B-Cell Lymphoma

Management of Grade 3B Follicular Lymphoma (FL) Outside Clinical Trials: A Multicentric Retrospective Analysis on Behalf of Fondazione Italiana Linfomi (FIL)

Tumor Vs Normal Gene Expression Profiles Identify Deregulated Pathways in ETV6/RUNX1 Positive Acute Lymphoblastic Leukemia: A Microarray-Based Meta-Analysis

A Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes with Prognosis

Mirna-181a expression Lead to Longer Animal Survival and Slower Tumor-Growth Rate in Diffuse Large B-Cell Lymphoma Xenograft Models

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only